A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 31/445 (2006.01) A61K 31/70 (2006.01) A61K 38/00 (2006.01) A61K 45/00 (2006.01) A61K 45/08 (2006.01) A61K 48/00 (2006.01) A61P 9/00 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) C07K 14/57 (2006.01) C07K 16/18 (2006.01) C12N 15/09 (2006.01) C12Q 1/02 (2006.01) C12Q 1/42 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2352599
The invention is a method for treating cardiac hypertrophy, or other preventing other growth of cardiac and vascular tissue, through the use of NF- AT antagonists.
Cette invention se rapporte à un procédé servant à traiter l'hypertrophie cardiaque ou à prévenir toute croissance de tissus cardiaques et vasculaires grâce à l'utilisation d'antagonistes NF-AT.
Crabtree Gerald R.
Ho Steffan N.
Northrop Jeffrey P.
Borden Ladner Gervais Llp
The Board Of Trustees Of The Leland Stanford Junior University
LandOfFree
Nf-at mediates cardiac hypertrophy, methods and reagents... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nf-at mediates cardiac hypertrophy, methods and reagents..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nf-at mediates cardiac hypertrophy, methods and reagents... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2081873